bluebird bio, Inc. (LON:0HOH)

Verve Therapeutics Market Cap

bluebird bio is not actively traded anymore. When bluebird bio last traded, it had a market cap or net worth of $35.88 million.

• Market Cap: 35.88M
• Enterprise Value: 137.79M
• Revenue: 80.45M
• Ranking: n/a
• PE Ratio: n/a
• Stock Price: $3.90

Market Cap Chart

Since June 19, 2013, bluebird bio's market cap has decreased from 392.09M to 35.88M, a decrease of -90.85%. That is a compound annual growth rate of -18.13%.

Market Cap History

Date	Market Cap	% Change
May 30, 2025	36.12M	-44.24%
Dec 31, 2024	64.77M	-68.98%
Dec 29, 2023	208.82M	-56.15%
Dec 30, 2022	476.17M	-7.94%
Dec 31, 2021	517.24M	-75.41%
Dec 31, 2020	2.10B	-42.62%